Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2022
In 2022, some 21 percent of the company's total revenues were issued on research and development. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany. This statistic shows Boehringer Ingelheim's expenditure on research and development as a percentage of revenues between 2004 and 2022.